Eurospital

Dequadin Solution For Oral Mucosa

Gingivitis Treatment Stomatitis Tonsillitis; Bottle 28ml

Active principles

DEQUADIN 0.5% oral mucosal solution 100 ml of oral mucosal solution contain: Active ingredient: 0.5 g dequalinium chloride. DEQUADIN 0.5% oral mucosal solution and DEQUADIN 0.5% oral mucosal spray contain propylene glycol.

Excipients

DEQUADIN 0.5% solution for oral mucosa: Propylene glycol, ethyl alcohol, saccharin, purified water, benzyl alcohol, pink aroma, geranium essential oil.

Therapeutic indications

Solution for oral mucosa: Topical treatment in gingivitis, stomatitis, tonsillitis, in pharyngitis. After dental extractions DEQUADIN oral mucosal solution is useful for the prophylaxis of infections.

Contraindications

Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. In children under three years of age, especially if predisposed to laryngospasm or convulsions.

Dosage

DEQUADIN solution for oral mucosa: Adults: apply locally every 2–3 hours: use a brush or a cotton ball wrapped around a stick or the special spray dispenser in the 10 ml bottle. Children over the age of three: 2 to 5 local applications per day. In the topical treatment of infections of medium or mild severity, DEQUADIN Solution for oral mucosa, gargle or mouthwash can be used: dilute 10-20 drops of solution in a glass of water and apply 3 times a day. It is advisable to keep the mouth open and not to swallow the saliva for a few minutes after applying the solution: in this way the maximum therapeutic efficacy is obtained. Do not exceed the recommended dose.

Warnings and Precautions

The use, especially if prolonged, of products for topical use can give rise to sensitization phenomena; if this occurs, treatment must be suspended and appropriate therapy instituted. The same applies to the development of resistant microorganisms. Oromucosal Spray and Oromucosal Solution: Use should be limited to lesions of the mouth and throat.

Interactions

Avoid the simultaneous use of other antiseptics and detergents.

Side effects

The use of the medicine can cause local irritation. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit / risk ratio of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.agenziafarmaco.gov.it/it/responsabili.

Pregnancy and breastfeeding

There are no known contraindications.